FDA Drug Recalls

Recalls / Class II

Class IID-0378-2025

Product

Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00

Affected lot / code info
Lot J0826722-121624 Exp. 12/31/2025 Lot J0820365-111324 Exp. 11/30/2025 Lot J0814691-101624 Exp. 10/31/2025

Why it was recalled

CGMP Deviations

Recalling firm

Firm
RemedyRepack Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
625 Kolter Dr Ste 4, N/A, Indiana, Pennsylvania 15701-3571

Distribution

Quantity
1,858 30-count blister cards
Distribution pattern
PA

Timeline

Recall initiated
2025-03-24
FDA classified
2025-04-18
Posted by FDA
2025-04-30
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0378-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls